Dipeptidyl peptidase 4 inhibitors in COVID-19: Beyond glycemic control

doi:10.5501/wjv.v11.i6.399

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2555)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

121

WORD

HTML

1145

Figures (1-2)

160

Tables (1-2)

211

Sum=1692

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

252

Download

611

Sum=863

Nov 25, 2022 (publication date) through Jul 11, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Virology

ISSN

2220-3249

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Virol. Nov 25, 2022; 11(6): 399-410
Published online Nov 25, 2022. doi: 10.5501/wjv.v11.i6.399

Open in New Tab Full Size Figure Download Figure

Figure 1 Proposed mechanisms of dipeptidyl peptidase-4 inhibitors in coronavirus disease 2019 infection. ACE2R: Angiotensin converting enzyme 2 receptor; COVID-19: Coronavirus disease 2019; DPP-4: Dipeptidyl peptidase-4; FOXP3: Forkhead box P3; IL: Interleukin; mDPP4: Membrane bound DPP4; sDPP4: Soluble DPP4; TGF-β: Transforming growth factor beta.

Open in New Tab Full Size Figure Download Figure

Figure 2 Hypothetical interactions between dipeptidyl peptidase-4 and severe acute respiratory syndrome coronavirus 2 virus. ACE-2: Angiotensin-converting enzyme 2; ACE2R: Angiotensin converting enzyme 2 receptor; DPP-4: Dipeptidyl peptidase-4; mDPP4: Membrane bound DPP4; sDPP4: Soluble DPP4.

Citation: Narayanan N, Naik D, Sahoo J, Kamalanathan S. Dipeptidyl peptidase 4 inhibitors in COVID-19: Beyond glycemic control. World J Virol 2022; 11(6): 399-410
URL: https://www.wjgnet.com/2220-3249/full/v11/i6/399.htm
DOI: https://dx.doi.org/10.5501/wjv.v11.i6.399